Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/03/012305
CTRI/2018/03/012305
Completed
未知

A study to evaluate the Opthalmologic and Dermatologic safety of the Under Eye Serums by Repeat Use Test (7 days) in Healthy Subjects with Equal Representation of Different Skin Types. - NI

ITC Life Sciences Technology Centre0 sites72 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ITC Life Sciences Technology Centre
Enrollment
72
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 30, 2016
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ITC Life Sciences Technology Centre

Eligibility Criteria

Inclusion Criteria

  • •1\.Subjects in generally good health.
  • •2\.Subjects willing to abide by the study requirements and protocol.
  • •Special criteria:
  • •3\.Equal representation of subjects with visible Finelines and / or Wrinkles, Under Eye Puffiness and Under eye dark circles in both groups
  • •4\.Atleast 18 Subjects with visible Finelines and / or Wrinkles
  • •5\.Atleast 18 Subjects with Under Eye Puffiness
  • •6\.Atleast 18 Subjects with Under Eye Dark circles
  • •7\.Equal representation of different skin types\- Normal, Oily, Dry and Combination Sensitive.
  • •8\.Subjects of varied eye conditions such as normal condition, sensitive condition and contact lens users

Exclusion Criteria

  • •1\.Women subjects who are pregnant or lactating
  • •2\.A known history or present condition of allergic response to any cosmetic products (eye/ facial cosmetic products).
  • •3\.Subjects having eye infection or allergy.
  • •4\.Subjects having extremely sensitive eye condition.
  • •5\.Subjects having any form cutaneous disease which may influence the study result.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
To evaluate opthalmological and dermatological safety of skin care products
CTRI/2021/11/038306SERY COSMETICS LLP30
Unknown
Not Applicable
Clinical study about the ocular administration of the anti-VEGF antibody for the retinopathy of prematurity
JPRN-UMIN000025361ara Medical University20
Completed
Phase 3
Comparison, effect of Ophthalmic ointment tetracycline1% and erythromycin 0.5% in prophylaxis of ophthalmia Neonatorum.Condition 1: neonatal conjunctivitis. Condition 2: Gonococcal conjunctivitis.Neonatal conjunctivitisGonococcal infection of eye
IRCT201101295714N1niversity of Medical Sciences Vice chancellor for research, Kordistan330
Completed
Not Applicable
To test the safety of hydration mist on eyes during usage.
CTRI/2023/05/053058DPKA Universal Consumer Ventures Private Limited33
Recruiting
Not Applicable
Evaluation of ocular pathological condition using polarization-sensitive optical coherence tomographyGlaucoma, Glaucoma after trabeculectomy, Keratoconus, Corneal dystrophy, Pterygium, Inflammatory anterior eye diseases, Cataract
JPRN-UMIN000014774Department of Ophthalmology, Tohoku University Graduate School of Medicine180